[go: up one dir, main page]

MA28603B1 - Composition pharmaceutique antimycobacterienne - Google Patents

Composition pharmaceutique antimycobacterienne

Info

Publication number
MA28603B1
MA28603B1 MA29484A MA29484A MA28603B1 MA 28603 B1 MA28603 B1 MA 28603B1 MA 29484 A MA29484 A MA 29484A MA 29484 A MA29484 A MA 29484A MA 28603 B1 MA28603 B1 MA 28603B1
Authority
MA
Morocco
Prior art keywords
pharmaceutical composition
antimycobacterial pharmaceutical
antimycobacterial
composition
pharmaceutical
Prior art date
Application number
MA29484A
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Neelima Sinha
Rakesh Sinha
Ram Shankar Upadhyaya
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of MA28603B1 publication Critical patent/MA28603B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/131—Amines acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29484A 2004-05-12 2006-11-23 Composition pharmaceutique antimycobacterienne MA28603B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/844,992 US7491721B2 (en) 2004-05-12 2004-05-12 Antimycobacterial pharmaceutical composition

Publications (1)

Publication Number Publication Date
MA28603B1 true MA28603B1 (fr) 2007-05-02

Family

ID=34960626

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29484A MA28603B1 (fr) 2004-05-12 2006-11-23 Composition pharmaceutique antimycobacterienne

Country Status (45)

Country Link
US (1) US7491721B2 (fr)
EP (1) EP1750765B1 (fr)
JP (1) JP2007537242A (fr)
KR (1) KR100854309B1 (fr)
CN (1) CN1956732B (fr)
AP (1) AP1994A (fr)
AR (1) AR048948A1 (fr)
AT (1) ATE373488T1 (fr)
AU (1) AU2004319259A1 (fr)
BR (1) BRPI0418770A (fr)
CA (1) CA2566440C (fr)
CR (1) CR8748A (fr)
DE (1) DE602004009113T2 (fr)
DK (1) DK1750765T3 (fr)
DO (1) DOP2005000085A (fr)
EA (1) EA009694B1 (fr)
EC (1) ECSP066965A (fr)
ES (1) ES2294577T3 (fr)
GE (1) GEP20094805B (fr)
HK (1) HK1098962A1 (fr)
HN (1) HN2005000210A (fr)
HR (1) HRP20070574T3 (fr)
IL (1) IL178858A (fr)
IS (1) IS8559A (fr)
JO (1) JO2471B1 (fr)
MA (1) MA28603B1 (fr)
MX (1) MXPA06012984A (fr)
MY (1) MY139187A (fr)
NI (1) NI200600270A (fr)
NO (1) NO20065725L (fr)
NZ (1) NZ550892A (fr)
PA (1) PA8633001A1 (fr)
PE (1) PE20060353A1 (fr)
PL (1) PL1750765T3 (fr)
PT (1) PT1750765E (fr)
RS (1) RS20060624A (fr)
SA (1) SA05260130B1 (fr)
SI (1) SI1750765T1 (fr)
SM (1) SM200500011B (fr)
SV (1) SV2006002109A (fr)
TN (1) TNSN06349A1 (fr)
UA (1) UA82782C2 (fr)
UY (1) UY28893A1 (fr)
WO (1) WO2005107809A2 (fr)
ZA (1) ZA200608843B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1871742A1 (fr) * 2005-04-11 2008-01-02 Lupin Ltd. Préparation de dérivés de ý2-méthyl-5-phényl-3-(pipérazine-1-ylméthyl)¨pyrrole
JP5339840B2 (ja) 2008-10-02 2013-11-13 公益財団法人微生物化学研究会 抗ｘｄｒ−ｔｂ薬、抗ｍｄｒ−ｔｂ薬、及び併用抗結核薬
US9198913B2 (en) * 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
MX2012002910A (es) * 2009-09-11 2012-04-19 Vertex Pharma Composiciones de n-bencil-3-(4-clorofenil)-2-[metil-[2-oxo-2-(3,4, 5-trietoxifenil)acetil]amino]-n-[3-(4-piridil)-1-[2-(4-piridil)et il]propil]propanamida y usos de las misma.
HUP1000033A2 (en) * 2010-01-21 2011-07-28 Uratim Kft Piperazine derivatives useful against mycobacteriums
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same
CN118743705B (zh) * 2024-08-12 2024-11-15 深圳大学 药物组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227383A (en) * 1991-06-14 1993-07-13 The University Of Mississippi Compounds and compositions useful as antifungal and antimycobacterial agents
NZ539449A (en) * 2002-09-20 2007-08-31 Lupin Ltd Pyrrole derivatives as anti-microbacterial compounds

Also Published As

Publication number Publication date
CA2566440C (fr) 2009-08-04
ES2294577T3 (es) 2008-04-01
SI1750765T1 (sl) 2008-04-30
BRPI0418770A (pt) 2007-10-09
ATE373488T1 (de) 2007-10-15
KR100854309B1 (ko) 2008-08-26
EP1750765A2 (fr) 2007-02-14
SA05260130B1 (ar) 2008-05-04
NI200600270A (es) 2007-12-11
IL178858A0 (en) 2007-03-08
ZA200608843B (en) 2008-07-30
SM200500011A (it) 2005-11-16
UY28893A1 (es) 2005-12-30
AU2004319259A1 (en) 2005-11-17
PE20060353A1 (es) 2006-07-08
EP1750765B1 (fr) 2007-09-19
TNSN06349A1 (en) 2008-02-22
AP2006003807A0 (en) 2006-12-31
DK1750765T3 (da) 2008-01-28
WO2005107809A8 (fr) 2006-05-18
NO20065725L (no) 2006-12-12
JP2007537242A (ja) 2007-12-20
RS20060624A (en) 2008-09-29
DE602004009113T2 (de) 2008-06-19
CR8748A (es) 2008-06-02
CA2566440A1 (fr) 2005-11-17
DE602004009113D1 (de) 2007-10-31
HRP20070574T3 (en) 2008-01-31
HK1098962A1 (en) 2007-08-03
ECSP066965A (es) 2006-12-20
SM200500011B (it) 2005-11-16
NZ550892A (en) 2009-12-24
IS8559A (is) 2006-10-26
EA200601952A1 (ru) 2007-02-27
EA009694B1 (ru) 2008-02-28
KR20070007920A (ko) 2007-01-16
PT1750765E (pt) 2007-12-31
PA8633001A1 (es) 2006-12-07
AR048948A1 (es) 2006-06-14
MY139187A (en) 2009-08-28
US7491721B2 (en) 2009-02-17
WO2005107809A3 (fr) 2006-01-26
IL178858A (en) 2010-06-16
GEP20094805B (en) 2009-10-26
SV2006002109A (es) 2006-04-18
CN1956732B (zh) 2010-04-28
PL1750765T3 (pl) 2008-02-29
WO2005107809A2 (fr) 2005-11-17
JO2471B1 (en) 2009-01-20
CN1956732A (zh) 2007-05-02
HN2005000210A (es) 2009-03-17
DOP2005000085A (es) 2007-01-15
UA82782C2 (uk) 2008-05-12
AP1994A (en) 2009-04-09
MXPA06012984A (es) 2007-04-23
US20050256128A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
BRPI0511900A (pt) composições farmacêuticas
RU2398586C3 (ru) Фармацевтическая композиция
MA28489B1 (fr) Preparations pharmaceutiques
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
EP1871347A4 (fr) Preparation pharmaceutique
DK1587478T3 (da) Farmaceutisk sammensætning
DK1725218T3 (da) Farmaceutisk sammensætning omfattende pimobendan
EP1937255A4 (fr) Composition pharmaceutique
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
EP1862184A4 (fr) Composition pharmaceutique
DK2033629T3 (da) Fast farmaceutisk sammensætning omfattende valsartan
BRPI0614413A2 (pt) composto, e, composição farmacêutica
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
BRPI0614412A2 (pt) composto, e, composição farmacêutica
DK1791530T3 (da) Farmaceutisk komposition indeholdende et psykostimulerende middel
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
FR2880807B1 (fr) Composition pharmaceutique injectable
EP1747205A4 (fr) Compositions pharmaceutiques
DK1753431T3 (da) Farmaceutisk sammensætning omfattende ZD6474
DE112004001429D2 (de) Pharmazeutischer Wirkstoff
SE0402637D0 (sv) Pharmaceutical use
SE0402639D0 (sv) Pharmaceutical use